Interaction with a Biomolecule Facilitates the Formation of the Function-Determining Long-Lived Triplet State in a Ruthenium Complex for Photodynamic Therapy
- PMID: 35179905
- PMCID: PMC8903189
- DOI: 10.1021/acs.jpca.1c09968
Interaction with a Biomolecule Facilitates the Formation of the Function-Determining Long-Lived Triplet State in a Ruthenium Complex for Photodynamic Therapy
Abstract
TLD1433 is the first ruthenium (Ru)-based photodynamic therapy (PDT) agent to advance to clinical trials and is currently in a phase II study for treating nonmuscle bladder cancer with PDT. Herein, we present a photophysical study of TLD1433 and its derivative TLD1633 using complex, biologically relevant solvents to elucidate the excited-state properties that are key for biological activity. The complexes incorporate an imidazo [4,5-f][1,10]phenanthroline (IP) ligand appended to α-ter- or quaterthiophene, respectively, where TLD1433 = [Ru(4,4'-dmb)2(IP-3T)]Cl2 and TLD1633 = [Ru(4,4'-dmb)2(IP-4T)]Cl2 (4,4'-dmb = 4,4'-dimethyl-2,2'-bipyridine; 3T = α-terthiophene; 4T = α-quaterthiophene). Time-resolved transient absorption experiments demonstrate that the excited-state dynamics of the complexes change upon interaction with biological macromolecules (e.g., DNA). In this case, the accessibility of the lowest-energy triplet intraligand charge-transfer (3ILCT) state (T1) is increased at the expense of a higher-lying 3ILCT state. We attribute this behavior to the increased rigidity of the ligand framework upon binding to DNA, which prolongs the lifetime of the T1 state. This lowest-lying state is primarily responsible for O2 sensitization and hence photoinduced cytotoxicity. Therefore, to gain a realistic picture of the excited-state kinetics that underlie the photoinduced function of the complexes, it is necessary to interrogate their photophysical dynamics in the presence of biological targets once they are known.
Conflict of interest statement
S.A.M. has a potential research conflict of interest due to a financial interest with Theralase Technologies, Inc. and PhotoDynamic, Inc. A management plan has been created to preserve objectivity in research in accordance with UTA policy
Figures





Similar articles
-
Ru(II) Phenanthroline-Based Oligothienyl Complexes as Phototherapy Agents.Inorg Chem. 2023 Dec 25;62(51):21181-21200. doi: 10.1021/acs.inorgchem.3c03216. Epub 2023 Dec 11. Inorg Chem. 2023. PMID: 38079387 Free PMC article.
-
String-Attached Oligothiophene Substituents Determine the Fate of Excited States in Ruthenium Complexes for Photodynamic Therapy.J Phys Chem A. 2021 Aug 19;125(32):6985-6994. doi: 10.1021/acs.jpca.1c04900. Epub 2021 Aug 9. J Phys Chem A. 2021. PMID: 34370485 Free PMC article.
-
Excited State Dynamics of a Photobiologically Active Ru(II) Dyad Are Altered in Biologically Relevant Environments.J Phys Chem A. 2017 Aug 3;121(30):5635-5644. doi: 10.1021/acs.jpca.7b04670. Epub 2017 Jul 25. J Phys Chem A. 2017. PMID: 28678497
-
Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.Acc Chem Res. 2017 Nov 21;50(11):2727-2736. doi: 10.1021/acs.accounts.7b00180. Epub 2017 Oct 23. Acc Chem Res. 2017. PMID: 29058879 Review.
-
Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433.Chem Rev. 2019 Jan 23;119(2):797-828. doi: 10.1021/acs.chemrev.8b00211. Epub 2018 Oct 8. Chem Rev. 2019. PMID: 30295467 Free PMC article. Review.
Cited by
-
Leveraging the Photofunctions of Transition Metal Complexes for the Design of Innovative Phototherapeutics.Small Methods. 2024 Nov;8(11):e2400563. doi: 10.1002/smtd.202400563. Epub 2024 Sep 25. Small Methods. 2024. PMID: 39319499 Free PMC article. Review.
-
Using Biological Photophysics to Map the Excited-State Topology of Molecular Photosensitizers for Photodynamic Therapy.Angew Chem Int Ed Engl. 2023 Apr 17;62(17):e202301452. doi: 10.1002/anie.202301452. Epub 2023 Mar 20. Angew Chem Int Ed Engl. 2023. PMID: 36827484 Free PMC article.
References
-
- Bonnett R Chemical Aspects of Photodynamic Therapy; CRC Press: London, 2000.
-
- Photodynamic Therapy: Basic Principles and Clinical Applications; Henderson BW, Dougherty TJ, Eds.; CRC Press: New York, 1992
-
- Handbook of Photomedicine, 1st ed.; Hamblin MR, Huang Y, Eds.; CRC Press: Boca Raton, FL, 2013.
-
- Hamblin MR; Mroz P Advances in Photodynamic Therapy: Basic, Translational, and Clinical; Engineering in Medicine and Biology; Artech House: Norwood, MA, 2008.
-
- Photodynamic Medicine: From Bench to Clinic, 1st ed.; Kostron H, Hasan T, Eds.; Royal Society of Chemistry: Cambridge, U.K., 2016.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources